Literature DB >> 32016036

CA19-9 as a therapeutic target in pancreatitis.

Shingo Kato1, Kazufumi Honda2.   

Abstract

Entities:  

Year:  2019        PMID： 32016036      PMCID： PMC6976502          DOI： 10.21037/atm.2019.09.161

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  15 in total

Review 1.  Inflammation in acute and chronic pancreatitis.

Authors:  Aida Habtezion
Journal:  Curr Opin Gastroenterol       Date:  2015-09       Impact factor: 3.287

2.  Colorectal carcinoma antigens detected by hybridoma antibodies.

Authors:  H Koprowski; Z Steplewski; K Mitchell; M Herlyn; D Herlyn; P Fuhrer
Journal:  Somatic Cell Genet       Date:  1979-11

3.  EGF receptor is required for KRAS-induced pancreatic tumorigenesis.

Authors:  Christine M Ardito; Barbara M Grüner; Kenneth K Takeuchi; Clara Lubeseder-Martellato; Nicole Teichmann; Pawel K Mazur; Kathleen E Delgiorno; Eileen S Carpenter; Christopher J Halbrook; Jason C Hall; Debjani Pal; Thomas Briel; Alexander Herner; Marija Trajkovic-Arsic; Bence Sipos; Geou-Yarh Liou; Peter Storz; Nicole R Murray; David W Threadgill; Maria Sibilia; M Kay Washington; Carole L Wilson; Roland M Schmid; Elaine W Raines; Howard C Crawford; Jens T Siveke
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

4.  EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma.

Authors:  Carolina Navas; Isabel Hernández-Porras; Alberto J Schuhmacher; Maria Sibilia; Carmen Guerra; Mariano Barbacid
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

5.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

Authors:  Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

6.  Persistent elevation of serum CA 19-9 with no evidence of malignant disease.

Authors:  M Ventrucci; P Pozzato; A Cipolla; G Uomo
Journal:  Dig Liver Dis       Date:  2008-07-03       Impact factor: 4.088

7.  CA19-9 as a screening and diagnostic tool in symptomatic patients: the Japanese experience.

Authors:  K Satake; T Takeuchi; T Homma; H Ozaki
Journal:  Pancreas       Date:  1994-11       Impact factor: 3.327

8.  Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium.

Authors:  A Takada; K Ohmori; T Yoneda; K Tsuyuoka; A Hasegawa; M Kiso; R Kannagi
Journal:  Cancer Res       Date:  1993-01-15       Impact factor: 12.701

9.  The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice.

Authors:  Dannielle D Engle; Hervé Tiriac; Keith D Rivera; Arnaud Pommier; Sean Whalen; Tobiloba E Oni; Brinda Alagesan; Eun Jung Lee; Melissa A Yao; Matthew S Lucito; Benjamin Spielman; Brandon Da Silva; Christina Schoepfer; Kevin Wright; Brianna Creighton; Lauren Afinowicz; Kenneth H Yu; Robert Grützmann; Daniela Aust; Phyllis A Gimotty; Katherine S Pollard; Ralph H Hruban; Michael G Goggins; Christian Pilarsky; Youngkyu Park; Darryl J Pappin; Michael A Hollingsworth; David A Tuveson
Journal:  Science       Date:  2019-06-21       Impact factor: 63.714

10.  A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer.

Authors:  Johannes F Fahrmann; Leonidas E Bantis; Michela Capello; Ghislaine Scelo; Jennifer B Dennison; Nikul Patel; Eunice Murage; Jody Vykoukal; Deepali L Kundnani; Lenka Foretova; Eleonora Fabianova; Ivana Holcatova; Vladimir Janout; Ziding Feng; Michele Yip-Schneider; Jianjun Zhang; Randall Brand; Ayumu Taguchi; Anirban Maitra; Paul Brennan; C Max Schmidt; Samir Hanash
Journal:  J Natl Cancer Inst       Date:  2019-04-01       Impact factor: 13.506
View more
  1 in total

1.  Combination of Changes in CEA and CA199 Concentration After Neoadjuvant Chemoradiotherapy Could Predict the Prognosis of Stage II/III Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.

Authors:  Jieyi Zhao; Huamin Zhao; Tingting Jia; Shiru Yang; Xiaoyu Wang
Journal:  Cancer Manag Res       Date:  2022-09-29       Impact factor: 3.602
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.